{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262944561099264.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1097/hjh.0000000000000379"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/10.1097/HJH.0000000000000379"}}],"dc:title":[{"@value":"Effects of blood pressure lowering on outcome incidence in hypertension"}],"dcterms:alternative":[{"@value":"2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262944561099265","@type":"Researcher","foaf:name":[{"@value":"Costas Thomopoulos"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561099266","@type":"Researcher","foaf:name":[{"@value":"Gianfranco Parati"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561099264","@type":"Researcher","foaf:name":[{"@value":"Alberto Zanchetti"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"02636352"}],"prism:publicationName":[{"@value":"Journal of Hypertension"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2014-12","prism:volume":"32","prism:number":"12","prism:startingPage":"2296","prism:endingPage":"2304"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/10.1097/HJH.0000000000000379"}],"createdAt":"2014-09-25","modifiedAt":"2021-05-14","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390564238077131776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?　― An Asian Perspective ―"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/hjh.0000000000000379"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-18-1293_references_DOI_FKMTA78EEpzFVfbsO6aWRjXPflQ"}]}